Fady Boctor
President & Chief Commercial Officer · Petros Pharmaceuticals, Inc.
Individual
- 2026
- Jun 5, 2026
- 1
Filings (90d)
0
Other insiders active in the same sector
No other insider has filed at Fady Boctor's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Michael Simanovsky - $110.65M in SNDA purchases and sales in the last 12 months
- Mayukh Sukhatme - $109.13M in ROIV purchases and sales in the last 12 months
- Emily M. Leproust - $101.55M in TWST purchases and sales in the last 12 months
- Bruce Booth - $100.59M in KYMR purchases and sales in the last 12 months
- Paul A. Mahon - $98.96M in UTHR purchases and sales in the last 12 months
- Herriot Tabuteau - $97.80M in AXSM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Fady Boctor?
Fady Boctor is a corporate insider, tracked as President & Chief Commercial Officer of Petros Pharmaceuticals, Inc. (PTPI). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Fady Boctor last file a Form 4?
The only primary Form 4 on record is dated 5 June 2026.
